Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Melhem Ghaleb

Vascular & Interventional Radiology El Paso, TX Medical Doctor

NPI 1043201627 CMS profile 92182

4815 Alameda Ave, El Paso, TX 79905

Open in the dashboard

General payments

$117,801

368 records reported · program years 2019–2025

Research payments

$281

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Melhem Ghaleb of El Paso, TX is reported in the CMS Open Payments database as having received $117,801 across 368 general payments and $281 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $50,163 130
2024 General $27,317 110
2023 General $28,884 88
2023 Research $281 1
2022 General $10,632 28
2021 General $668 10
2020 General $21 1
2019 General $116 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Melhem Ghaleb
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Melhem Ghaleb were reported at $50,163. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Melhem Ghaleb Vascular & Interventional Radiology median Middle half National median
2019 $116 $422 $125–$1,555 $163
2020 $21 $200 $68–$652 $114
2021 $668 $280 $99–$866 $132
2022 $10,632 $433 $137–$1,497 $149
2023 $28,884 $506 $152–$2,019 $160
2024 $27,317 $556 $175–$1,930 $164
2025 $50,163 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $29,914 105 payments
  2. Penumbra, Inc. $28,052 66 payments
  3. Terumo Medical Corporation $23,755 50 payments
  4. Stryker Corporation $13,126 28 payments
  5. Inari Medical, Inc. $13,109 48 payments
  6. Argon Medical Devices, Inc. $5,705 8 payments
  7. Nevro Corp. $1,949 23 payments
  8. Boston Scientific Corporation $314 7 payments
  9. Globus Medical, Inc. $303 3 payments
  10. AngioDynamics, Inc. $236 4 payments
  11. Other $1,339 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $38,363 35 payments
  2. Travel and Lodging $29,614 74 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $26,225 12 payments
  4. Food and Beverage $18,216 244 payments
  5. Honoraria $5,382 3 payments
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $25,936 66 payments
  2. CT THROMBECTOMY SYSTEM KIT $25,498 60 payments
  3. Azur CX Detachable $21,777 43 payments
  4. Indigo System $21,066 47 payments
  5. IN.PACT Admiral $7,415 5 payments
  6. MVP $6,299 4 payments
  7. Clot Management $5,705 8 payments
  8. RUBY Coil $4,491 6 payments
  9. Riptide $3,727 6 payments
  10. Concerto Versa $3,260 3 payments
  11. Other $15,144 173 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $281 1 payment

Billing to Medicare

Part B · data year 2024 · 110 billing codes

Paid by Medicare

$51,608

Medicare's payments for the services billed

Medicare patients

206

Average age 76

Services billed

424

110 women, 96 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 65%
Chronic kidney disease 54%
Arthritis 50%
Heart failure 46%
Ischemic heart disease 44%
Atrial fibrillation 37%
Depression 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENTRESTO
  • Novartis Pharmaceuticals Corporation $41
$41 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

369 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record